|
|
|
1025: Repeated Proton Beam Therapy for Hepatocellular Carcinoma
|
Hashimoto, Takayuki |
|
1026: Feasibility Study of Real-Time Tumor-Tracking Radiotherapy (RTRT) for Highly-Selected Patients with HepatocellularCarcinoma (HCC) Untreatable with Other Modalities
|
Taguchi, Hiroshi |
|
1027: Three-Dimensional Conformal Radiotherapy (3DCRT) Combined with Transcatheter Arterial Chemoembolization (TACE) for Inoperable or Unresectable Hepatocellular Carcinoma (HCC): Clinical Phase I/II Trial
|
Jiang, Guoliang |
|
1028: Treatment of Unresectable Chemorefractory Liver Metastases with Selective Intrahepatic Application of Yttrium-90 Microspheres (SIR-Spheres): Early U.S. Experience
|
Garofalo, Michael |
|
1029: Early Detection of Chemoradiotherapy Response in Esophageal Carcinoma by Fluorothymidine (FLT) PET Imaging
|
Smith, Apisarnthanarax |
|
1030: A Phase II Study Of Preoperative Conformal Radiotherapy and Chemotherapy (CPTII/Cisplatin) for Esophageal Cancer
|
Wong, Rebecca |
|
1031: Dose-Volume Analyses of Postoperative Lung Complications in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy Followed by Surgery
|
Wang, Shulian |
|
1032: Clinical Results of Proton Beam Therapy for Esophageal Cancer at the University of Tsukuba
|
Sugahara, Shinji |
|
1033: Neoadjuvant Chemoradiation with Capecitabine versus Infusional 5-fluorouracil (5-FU) for Locally Advanced Rectal Cancer: a Matched Pair Analysis
|
Das, Prajnan |
|
1034: Impact of Pretreatment Tumor Size and Lymph Nodes on Pathologic Complete Response and Survival in a Prospective Trial of Chemoradiation for Locally Advanced Rectal Cancer
|
Kim, Catherine |
|
1035: To Determine the Volume of Bowel and Dose Received in the Pelvic Radiation Field for Rectal Cancer in the Prone and Supine Position
|
Tait, Diana |
|
1036: Confirmation of the Dose-Volume Relationship for Acute Small Bowel Toxicity During the Treatment of Rectal Cancer
|
Robertson, John |
|
1037: Carcinoma of the Ampulla of Vater: Patterns of Failure after Resection and Possible Benefit of Adjuvant Radiotherapy
|
Czito, Brian |
|
1038: Gemcitabine Improves the Treatment Results of Radiochemotherapy in Locally Advanced Pancreatic Cancer: Results of Two Consecutive Monoinstutional Studies
|
Berning, Dorothee |
|
1039: Toxicity, Survival and Predictors of Outcome in Patients Receiving Adjuvant Chemoradiation for Gastric Adenocarcinoma
|
Ringash, Jolie |
|
2074: Conditional Survival of Gallbladder Adenocarcinoma Treated with Radiotherapy: Analysis from the SEER Database
|
Fuller, Clifton |
|
2075: Induction Chemotherapy Improves Long-Term Survival of Patients with Resectable Esophageal Cancer Receiving Chemoradiotherapy Followed by Surgery
|
Jeter, Melenda |
|
2076: Adjuvant Concurrent Chemoradiation for Adenocarcinoma of the Ampulla of Vater
|
Swartz, Michael |
|
2077: Results of Radiation Therapy for Superficial Esophageal Cancer Using Standard Radiotherapy Method Recommended byJASTRO Study Group
|
Nemoto, Kenji |
|
2078: Effect of Time Interval Between Surgery and Preoperative Chemoradiotherapy with 5-Fluorouracil (5-FU) or 5-FU/Oxaliplatin (5FU/OX) for Rectal Cancer
|
Dolinsky, Christopher |
|
2079: Preoperative Chemoradiation and Local Excision for Selected T2-T3 Rectal Cancer Patients
|
De Paoli, Antonino |
|
2080: Extent of Microscopic Spread and Lymph Node Metastasis in Patients with Esophageal and Gastroesophageal Junction Carcinoma Treated by Surgical Resection Only
|
Gao, Xianshu |
|
2081: Postoperative Chemoradiotherapy in Gastric Cancer - Results of Two Parallel Phase I-II Studies of a Fixed Radiotherapy Regimen with Escalating Doses of Cisplatin and Capecitabine
|
Jansen, Edwin |
|
2082: Esophagogastric Anastomosis Inside or Outside of the Preoperative Radiation Field: Does it Matter?
|
Parsons, Alden |
|
2083: An Analysis of GTV Motion using 4D-CT in Patients Receiving Radiotherapy for Esophageal Cancer
|
Wiltshire, Kirsty |
|
2084: Results of Adjuvant Combined Modality Treatment for Rectal Cancer Patients with Synchronous Liver Metastasis Following Synchronous Rectal and Hepatic Resection
|
Kim, BoKyong |
|
2085: Impact of Combined External Radiotherapy on Survival in Gastric Cancer: A Systematic Review and Meta-Analysis
|
Fiorica, Francesco |
|
2086: Long Term Follow-Up of Patients of Intrahepatic Malignancies Treated with Iodine-125 Brachytherapy
|
Nag, Subir |
|
2087: Abdominal Organ Motion During Conformal Radiation
|
Kassam, Zahra |
|
2088: A Prospective Comparison Study of Liver Tumour Target Definition Based on Triphasic CT and Gadolinium MR
|
Voroney, Jon-Paul |
|
2089: Phase I Dose Escalation Study of CyberKnife Stereotactic Radiosurgery for Liver Malignancies
|
Lieskovsky, YeeYie |
|
2090: Erlotinib as a Radiosensitizer for Patients with Esophageal Cancer
|
Dobelbower, Michael |
|
2091: Genomic Polymorphisms of Angiogenesis Pathway Predict Radiosensitivity in Rectal Cancer
|
Zhang, Wu |
|
2092: Predictive Factors for Response of Rectal Cancer to Preoperative Chemoradiotherapy
|
Myerson, Robert |
|
2093: Primary Tumor Status Affects on the Treatment Process and the Outcome of Esophageal Cancer Patients Treated by Radiation Therapy: Results of the Patterns of Care Study
|
Kenjo, Masahiro |
|
2094: Post-Operative Adjuvant Radiochemotherapy in the Treatment of Gallbladder Cancer.
|
Baeza, Mario |
|
2095: Helical Tomotherapy SBRT for Liver Metastases: Recommendations for Potential Candidates Based on Tumor Size and Location.
|
Baisden, Joseph |
|
